11/19
01:17 pm
bgms
Cyclacel Pharmaceuticals (NASDAQ:BGMS) is now covered by analysts at
Weiss Ratings. They set a "sell (e+)" rating on the stock.
Low
Report
Cyclacel Pharmaceuticals (NASDAQ:BGMS) is now covered by analysts at
Weiss Ratings. They set a "sell (e+)" rating on the stock.
11/19
04:09 am
bgms
Cyclacel Pharmaceuticals (NASDAQ:BGMS) was upgraded by analysts at
Wall
Low
Report
Cyclacel Pharmaceuticals (NASDAQ:BGMS) was upgraded by analysts at
Wall